PYC 2.44% 20.0¢ pyc therapeutics limited

roche or new player ?, page-3

  1. 87 Posts.
    why i like PYC

    Roche - Announced Jan 2009, upfront payment ~$1.0 Million, Milestone payment $XX,000,000 circa July 2011 + royalties on any successful drugs developed as a result.

    MedImmune - Announced Aug 2010, upfront payment ~$1.5 Million, Milestone payment $98,000,000 circa Aug 2011 + royalties on any successful drugs developed as a result.

    Rumoured deal? - might be announced < 3 months, similar arrangement as above.


    Essentially if PYC can successfully get a Milestone payment out of one of these 2, potential 3 companies it will put a rocket under the share price.

    Doing the maths (correct me if I'm wrong), if, in the next 12 months MedImmune makes the payment of $98,000,000 to PYC, based purely on cash value, PYC would be valued at 35 cents (98m / 283m shares) or approximately 6x its value. However at those levels if would be a potential takeover target with a Value of $200 - $400 m or 12x ($0.70) � 23x ($1.40) its current share price.

 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.